Journal of Gastroenterology

, Volume 42, Issue 7, pp 560–566

Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities

  • Keiichi Fujiwara
  • Osamu Yokosuka
  • Fumio Imazeki
  • Makoto Miki
  • Kazuyuki Suzuki
  • Kiwamu Okita
  • Eiji Tanaka
  • Masao Omata
Liver, Pancreas, and Biliary Tract



In our recent study of the full-length hepatitis A virus (HAV) genome from some patients with fulminant hepatitis and acute hepatitis, possible associations were suggested between the severity of hepatitis A and the amino acid substitutions in the nonstructural protein 2B. We therefore analyzed HAV 2B from many patients with various clinical disease severities.


Serum samples from 30 Japanese patients with sporadic hepatitis A from five widely separated regions of Japan, comprising nine patients with fulminant hepatitis (FH), six with severe acute hepatitis (AHs), and 15 with acute hepatitis (AH), were examined for HAV RNA. The entire sequences of HAV 2B were analyzed.


Compared with the sequence of the wild-type HAV strain GBM, nucleotide sequences of 2B had homology of 94.5 ± 1.0% in FH, 95.2 ± 1.2% in AHs, and 95.1 ± 1.8% in AH. Deduced amino acid sequences had homology of 97.5 ± 2.1% in FH, 97.9 ± 2.4% in AHs, and 98.5 ± 1.3% in AH. Differences were not statistically significant among the three groups. The average number of amino acid mutations between amino acids 100 and 200 was 5.0 ± 5.2 per case in FH, 4.0 ± 6.0 in AHs, and 1.9 ± 2.9 in AH. The differences between FH and AH, AHs and AH, and between severe cases (FH and AHs) and nonsevere cases (AH) were not statistically significant (P = 0.13, P = 0.45, and P = 0.10, respectively).


There were no obvious differences in the sequences among FH, AHs, and AH throughout the 2B region, but there seemed to be more mutations in the strains obtained from FH and AHs patients than in those obtained from AH patients in the central part of HAV 2B.

Key words

hepatitis A virus 2B fulminant hepatitis acute hepatitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Takahashi, Y, Okuda, K 1993Fulminant and subfulminant hepatitis in JapanIndian J Gastroenterol121921PubMedGoogle Scholar
  2. 2.
    Fujiwara, K, Ehata, T, Yokosuka, O, Imazeki, F, Ohto, M, Ohtake, Y,  et al. 1995The recent increase of severe type A hepatitis in Chiba areaInt Hepatol Commun3S37CrossRefGoogle Scholar
  3. 3.
    Fujiwara, K, Yokosuka, O, Ehata, T, Imazeki, F, Saisho, H 2000PCR-SSCP analysis of 5′ nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis ADig Dis Sci4524227CrossRefPubMedGoogle Scholar
  4. 4.
    Cohen, JI, Ticehurst, JR, Purcell, RH, Buckler-White, A, Baroudy, BM 1987Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picorna virusesJ Virol61509PubMedGoogle Scholar
  5. 5.
    Fujiwara, K, Yokosuka, O, Ehata, T, Imazeki, F, Saisho, H, Miki, M,  et al. 1997Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis AHepatology2616349CrossRefPubMedGoogle Scholar
  6. 6.
    Fujiwara, K, Yokosuka, O, Fukai, K, Imazeki, F, Saisho, H, Omata, M 2001Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitisJ Hepatol351129CrossRefPubMedGoogle Scholar
  7. 7.
    Fujiwara, K, Yokosuka, O, Ehata, T, Saisho, H, Saotome, N, Suzuki, K,  et al. 2002Association between severity of type A hepatitis and nucleotide variations in the 5′ nontranslated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutionsGut51828CrossRefPubMedGoogle Scholar
  8. 8.
    Jecht, M, Probst, C, Gauss-Muller, V 1998Membrane permeability induced by hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV 2BCVirology25221827CrossRefPubMedGoogle Scholar
  9. 9.
    Takahashi, Y, Shimizu, M 1991Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant HepatitisJ Gastroenterol Hepatol615964CrossRefPubMedGoogle Scholar
  10. 10.
    Okamoto, H, Okada, S, Sugiyama, Y, Tanaka, T, Sugai, Y, Akahane, Y,  et al. 1990Detection of hepatitis C virus RNA by a two-step polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding regionJpn J Exp Med6021522PubMedGoogle Scholar
  11. 11.
    Fujiwara, K, Yokosuka, O, Imazeki, F, Saisho, H, Saotome, N, Suzuki, K,  et al. 2003Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severitiesHepatol Res2512434CrossRefPubMedGoogle Scholar
  12. 12.
    Graff, J, Normann, A, Feinstone, SM, Flehmig, B 1994Nucleotide sequence of wild type hepatitis A virus GBM in comparison with two cell culture-adapted variantsJ Virol6854854PubMedGoogle Scholar
  13. 13.
    Muraoka, H 1990Clinical and epidemiological study on factors of serious development of viral hepatitis type ANippon Shokakibyo Gakkai Zasshi87138391PubMedGoogle Scholar
  14. 14.
    Willner, IR, Uhl, MD, Howard, SC, Williams, EQ, Riely, CA, Waters, B 1998Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United StatesAnn Intern Med1281114PubMedGoogle Scholar
  15. 15.
    Vento, S, Garofano, T, Renzini, C, Cainelli, F, Casali, F, Ghironzi, G,  et al. 1998Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis CN Engl J Med33828690CrossRefPubMedGoogle Scholar
  16. 16.
    Gosert, R, Egger, D, Bienz, K 2000A cytopathic and a cell culture adapted hepatitis A virus strain differ in cell killing but not in intracellular membrane rearrangementVirology26615769CrossRefPubMedGoogle Scholar
  17. 17.
    Emerson, SU, McRill, C, Rosenblum, B, Feinstone, SM, Purcell, RH 1991Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell cultureJ Virol6548826PubMedGoogle Scholar
  18. 18.
    Emerson, SU, Huang, Y-K, McRill, C, Lewis, M, Purcell, RH 1992Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaptation to growth in cell cultureJ Virol666504PubMedGoogle Scholar
  19. 19.
    Tedeschi, V, Purcell, RH, Emerson, SU 1993Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulenceJ Med Virol391622CrossRefPubMedGoogle Scholar
  20. 20.
    Funkhouser, AW, Purcell, RH, D'Hondt, E, Emerson, SU 1994Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cellsJ Virol6814857PubMedGoogle Scholar
  21. 21.
    Graff, J, Kasang, C, Normann, A, Pfisterer-Hunt, M, Feinstone, SM, Flehmig, B 1994Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptationVirology204608CrossRefPubMedGoogle Scholar
  22. 22.
    Beneduce, F, Psani, G, Divizia, M, Pana, A, Morace, G 1995Complete nucleotide sequence of a cytopathic hepatitis A virus strain isolated in ItalyVirus Res36299309CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang, H, Chao, S-F, Ping, LH, Grace, K, Clarke, B, Lemon, SM 1995An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effectVirology21268697CrossRefPubMedGoogle Scholar
  24. 24.
    Raychaudhuri, G, Govindarajan, S, Shapiro, M, Purcell, RH, Emerson, SU 1998Utilization of chimeras between human (HM-175) and simian (AGM-27) strains of hepatitis A virus to study the molecular basis of virulenceJ Virol72746775PubMedGoogle Scholar
  25. 25.
    Brack, K, Frings, W, Dotzauer, A, Vallbracht, A 1998A cytopathic, apoptosis-inducing variant of hepatitis A virusJ Virol7233706PubMedGoogle Scholar
  26. 26.
    Fujiwara K, Yokosuka O, Imazeki F, Miki M, Suzuki K, Okita K, et al. Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A. Hepatogastroenterology (in press)Google Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Keiichi Fujiwara
    • 1
  • Osamu Yokosuka
    • 1
  • Fumio Imazeki
    • 1
  • Makoto Miki
    • 2
  • Kazuyuki Suzuki
    • 3
  • Kiwamu Okita
    • 4
  • Eiji Tanaka
    • 5
  • Masao Omata
    • 6
  1. 1.Department of Medicine and Clinical OncologyGraduate School of Medicine, Chiba UniversityChibaJapan
  2. 2.Department of Internal MedicineYokohama Higashi National HospitalKanagawaJapan
  3. 3.First Department of Internal MedicineIwate Medical UniversityIwateJapan
  4. 4.Department of Gastroenterology and HepatologyYamaguchi University School of MedicineUbeJapan
  5. 5.Second Department of Internal MedicineShinshu University School of MedicineNaganoJapan
  6. 6.Department of Gastroenterology, Faculty of MedicineUniversity of TokyoTokyoJapan

Personalised recommendations